APA (7th ed.) Citation

Wijarnpreecha, K., Li, F., Dang, Y., Taner, C. B., Yang, L., & Tao, C. (2021). Letter: Hepatocellular carcinoma risk in patients with non‐selective beta blockers—authors' reply. Alimentary Pharmacology & Therapeutics, 54(8), 1095. https://doi.org/10.1111/apt.16598

Chicago Style (17th ed.) Citation

Wijarnpreecha, Karn, Fang Li, Yifang Dang, C. Burcin Taner, Liu Yang, and Cui Tao. "Letter: Hepatocellular Carcinoma Risk in Patients with Non‐selective Beta Blockers—authors' Reply." Alimentary Pharmacology & Therapeutics 54, no. 8 (2021): 1095. https://doi.org/10.1111/apt.16598.

MLA (9th ed.) Citation

Wijarnpreecha, Karn, et al. "Letter: Hepatocellular Carcinoma Risk in Patients with Non‐selective Beta Blockers—authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 54, no. 8, 2021, p. 1095, https://doi.org/10.1111/apt.16598.